Bank of America’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $8 | Buy |
|
|||||
|
2024
Q4 | $62 | Buy |
|
|||||
|
2024
Q3 | $151 | Hold |
|
|||||
|
2024
Q2 | $170 | Sell |
|
|||||
|
2024
Q1 | $3.55M | Sell |
|
|||||
|
2023
Q4 | $1.28M | Sell |
|
|||||
|
2023
Q3 | $1.47M | Buy |
|
|||||
|
2023
Q2 | $4.88K | Buy |
|
|||||
|
2023
Q1 | $3.02K | Sell |
|
|||||
|
2022
Q4 | $3K | Sell |
|
|||||
|
2022
Q3 | $10K | Sell |
|
|||||
|
2022
Q2 | $11K | Sell |
|
|||||
|
2022
Q1 | $51K | Sell |
|
|||||
|
2021
Q4 | $183K | Buy |
|
|||||
|
2021
Q3 | $165K | Buy |
|
|||||
|
2021
Q2 | $114K | Buy |
|
|||||
|
2021
Q1 | $3K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $7K | Buy |
|